GO:0045880 positive regulation of smoothened signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045880 describes any process that activates or increases the frequency, rate or extent of smoothened signaling, the core transduction arm of Hedgehog signaling.
• Positive regulation of smoothened signaling is driven by phosphorylation of GLI2/GLI3 by DYRK2, which amplifies GLI transcriptional output.
• Smoothened (SMO) is a G protein-coupled receptor-like protein that can also signal through Gαs-dependent cAMP changes, revealing non-canonical outputs of positive regulation.
• The RNA-binding protein Smaug is regulated by Smoothened via the kinase Fused, linking positive Smo signaling to post-transcriptional control.
• Dysregulated positive regulation of smoothened signaling contributes to chronic myeloid leukemia, sonic hedgehog medulloblastoma, and growth plate disorders [5,6,4].
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to dissect which components causally drive positive regulation of smoothened signaling.
Description
GO:0045880, positive regulation of smoothened signaling pathway, is a biological process Gene Ontology term that captures any event which activates or increases the frequency, rate or extent of smoothened signaling. Smoothened (SMO) is the central transducer of the Hedgehog (HH) pathway, and its positive regulation is required for normal embryonic patterning, stem cell maintenance and tissue homeostasis [1,8]. Because the term is defined by its effect on smoothened signaling rather than by a single molecular activity, it encompasses kinase-driven GLI activation, receptor-proximal modulation and downstream feedback that sustains pathway output [1,2]. Researchers study GO:0045880 to understand how cells amplify Hedgehog signals after ligand binding and how this amplification can become oncogenic. For example, DYRK2-mediated phosphorylation of GLI2 and GLI3 positively regulates Hedgehog signaling and is required for pathway-dependent transcription. In parallel, Smoothened activation can unexpectedly increase Gαs-dependent cAMP levels, showing that positive regulation of smoothened signaling includes outputs beyond canonical GLI activation. This article integrates the QuickGO definition with verified PubMed literature to explain the mechanism, key genes, disease links and experimental methods relevant to GO:0045880. It is written for researchers who need a precise, citable overview for grant writing, target discovery and CRISPR model design [1,2,5,6].
positive regulation of smoothened signaling pathway At A Glance
| GO ID | GO:0045880 |
|---|---|
| GO term | positive regulation of smoothened signaling pathway |
| Ontology | biological_process |
| Definition | Any process that activates or increases the frequency, rate or extent of smoothened signaling. |
| Synonyms | activation of smoothened signaling pathway; positive regulation of hedgehog signaling pathway; positive regulation of hh signaling pathway; positive regulation of smoothened by patched; positive regulation of smoothened receptor activity by patched; positive regulation of smoothened signalling pathway; stimulation of smoothened signaling pathway; up regulation of smoothened signaling pathway; up-regulation of smoothened signaling pathway; upregulation of smoothened signaling pathway |
| Major function | Amplification and maintenance of Smoothened-dependent Hedgehog signal transduction, including GLI activation and non-canonical outputs [1,7]. |
| Key upstream regulators | DYRK2 kinase, Fused kinase, Patched, Gαs-dependent cAMP signaling [1,2,7]. |
| Representative downstream effectors | GLI2, GLI3, Smaug RNA-binding protein [1,2]. |
| Disease relevance | Chronic myeloid leukemia, sonic hedgehog medulloblastoma, growth plate homeostasis disorders [5,6,4]. |
What Is GO:0045880?
In our own words, GO:0045880 refers to any biological process that activates or increases the frequency, rate or extent of smoothened signaling. Smoothened signaling is the intracellular signal transduction initiated by the Smoothened (SMO) protein, a key component of the Hedgehog pathway. Positive regulation therefore includes molecular events that enhance SMO activity, stabilize SMO-dependent signal transduction, or amplify downstream GLI-mediated transcription. The term is a biological process and is not restricted to a single gene or cell type; it can be fulfilled by kinases, RNA-binding proteins, G proteins and other modulators that quantitatively or qualitatively increase smoothened signaling output [1,2,7].
Why Is positive regulation of smoothened signaling pathway Important in Cell Biology?
Positive regulation of smoothened signaling is important because it determines the strength and duration of Hedgehog pathway output, which controls cell fate, proliferation and differentiation. When this positive regulation is excessive or constitutive, it can drive cancers such as chronic myeloid leukemia and sonic hedgehog medulloblastoma, and when it is disrupted it can cause skeletal growth plate abnormalities [5,6,4]. Understanding GO:0045880 therefore has direct implications for targeted therapy, stem cell biology and developmental disease research [1,5,6].
• Controls the amplitude of Hedgehog signaling, a pathway essential for embryonic development and adult tissue homeostasis [1,8].
• DYRK2-mediated phosphorylation of GLI2/GLI3 is a defined positive regulatory mechanism that sustains Hedgehog target gene expression.
• Smoothened activation can increase Gαs-dependent cAMP levels, expanding the functional outputs of positive regulation beyond canonical GLI transcription.
• Positive regulation of smoothened signaling is implicated in chronic myeloid leukemia stem/progenitor cell survival.
• Sonic hedgehog medulloblastoma depends on Smoothened pathway activity, and CRISPR screens have identified druggable dependencies in this context.
• Growth plate homeostasis requires Indian hedgehog signaling, and disruption of positive regulation can impair bone development.
• The RNA-binding protein Smaug is regulated by Smoothened via Fused, linking positive regulation to post-transcriptional gene control.
• Gastrointestinal stem cell signaling networks intersect with Hedgehog signaling, highlighting the broad relevance of GO:0045880.
• BCR-ABL signaling pathways interact with Hedgehog components, providing a rationale for dual targeting strategies [3,5].
• CRISPR-based models enable causal testing of positive regulators of smoothened signaling in disease-relevant cells.
What Happens During positive regulation of smoothened signaling pathway?
Initiation and relief of Smoothened inhibition
In simple terms: Positive regulation begins when the brake on Smoothened is released.
In the absence of Hedgehog ligand, Patched (PTCH1) restrains Smoothened activity. Positive regulation of smoothened signaling involves relief of this inhibition and subsequent activation of SMO-dependent transduction. The QuickGO synonyms explicitly include positive regulation of smoothened by patched and positive regulation of smoothened receptor activity by patched, indicating that de-repression of SMO by PTCH1 is a recognized component of this process.
Kinase-driven amplification of GLI transcription factors
In simple terms: Kinases add phosphate groups to GLI proteins to boost the signal.
DYRK2 kinase phosphorylates GLI2 and GLI3, and this phosphorylation positively regulates Hedgehog signaling by enhancing GLI transcriptional activity. This step represents a core mechanism of GO:0045880 because it directly increases the extent of smoothened signaling output at the level of downstream effectors.
Non-canonical G protein-dependent cAMP modulation
In simple terms: Smoothened can also raise cAMP through G proteins, adding another layer of positive regulation.
Activation of Smoothened in the Hedgehog pathway unexpectedly increases Gαs-dependent cAMP levels in Drosophila, demonstrating that positive regulation of smoothened signaling can proceed through G protein-coupled mechanisms in addition to canonical GLI activation. This finding broadens the definition of GO:0045880 to include modulation of second messenger systems.
Post-transcriptional control via Fused and Smaug
In simple terms: The signal also controls RNA-binding proteins that decide which mRNAs are used.
The RNA-binding protein Smaug is regulated by the GPCR Smoothened via the kinase Fused, linking positive Smoothened signaling to post-transcriptional regulation of gene expression. This represents a downstream amplification mechanism that can sustain or modify the positive regulation of smoothened signaling.
Integration with stem cell and growth factor signaling networks
In simple terms: Smoothened signaling talks to other pathways to fine-tune stem cell behavior.
Hedgehog signaling intersects with gastrointestinal stem cell signaling networks, and positive regulation of smoothened signaling can influence stem cell maintenance and proliferation. In the growth plate, Indian hedgehog signaling is required for homeostasis, and its positive regulation involves Smoothened-dependent transduction.
Key Genes Involved in GO:0045880 positive regulation of smoothened signaling pathway
The following genes and proteins are experimentally implicated in positive regulation of smoothened signaling pathway (GO:0045880) or its immediate downstream outputs.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SMO | Core transducer of Hedgehog signaling; subject of positive regulation | Central to GO:0045880; target of pathway activators and inhibitors [1,7] |
| PTCH1 | Inhibits Smoothened; relief of inhibition is a positive regulatory step | Synonym 'positive regulation of smoothened by patched' directly links PTCH1 to GO:0045880 |
| DYRK2 | Phosphorylates GLI2/GLI3 to enhance Hedgehog signaling | Direct positive regulator of smoothened signaling output |
| GLI2 | Transcription factor activated downstream of Smoothened | Phosphorylation by DYRK2 increases its activity |
| GLI3 | Transcription factor processed and regulated downstream of Smoothened | Phosphorylation by DYRK2 modulates its function |
| Fused | Kinase that regulates Smaug downstream of Smoothened | Links Smoothened to RNA-binding protein control |
| Smaug | RNA-binding protein regulated by Smoothened/Fused | Post-transcriptional effector of positive Smoothened signaling |
| Gαs | G protein subunit mediating cAMP increase upon Smoothened activation | Non-canonical positive regulation of smoothened signaling |
| BCR-ABL1 | Oncogenic kinase in chronic myeloid leukemia | Interacts with Hedgehog/Smoothened targeting strategies [3,5] |
| DNMT1 | DNA methyltransferase identified as dependency in SHH medulloblastoma | CRISPR screen hit in Smoothened-driven cancer |
| IHH | Indian hedgehog ligand upstream of Smoothened | Required for growth plate homeostasis |
| ADGRG6 | G protein-coupled receptor maintaining growth plate homeostasis via IHH signaling | Upstream modulator of Smoothened pathway |
| GLI1 | Transcriptional effector of Hedgehog signaling | Readout of positive smoothened signaling |
| SUFU | Negative regulator of GLI proteins | Context for positive regulation by DYRK2 |
| KIF7 | Cilia-associated regulator of Hedgehog signaling | Modulates GLI processing downstream of Smoothened |
| HHIP | Hedgehog-interacting protein, feedback antagonist | Feedback regulation of pathway output |
| PTCH2 | Patched family receptor | Modulates Smoothened activity |
| CDK1 | Cell cycle kinase that can influence GLI phosphorylation | Potential cross-talk with positive regulation |
How Is positive regulation of smoothened signaling pathway Regulated?
Positive regulation of smoothened signaling is itself subject to multiple layers of control. DYRK2 kinase activity determines the phosphorylation status of GLI2 and GLI3, thereby setting the gain of Hedgehog pathway output. The kinase Fused regulates the RNA-binding protein Smaug downstream of Smoothened, adding a post-transcriptional control layer. Gαs-dependent cAMP changes provide a non-canonical modulatory input that can alter the magnitude of smoothened signaling. In addition, Patched proteins restrain Smoothened, and relief of this inhibition is a prerequisite for positive regulation. Feedback antagonists such as HHIP and negative regulators such as SUFU further shape the duration and intensity of the response [1,8].
positive regulation of smoothened signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SMO | Chronic myeloid leukemia; medulloblastoma | CRISPR knockout or point-mutation in CML and SHH-MB cell lines [5,6] |
| BCR-ABL1 | Chronic myeloid leukemia | Dual targeting with Smoothened inhibitors in primary CML stem cells |
| DNMT1 | Sonic hedgehog medulloblastoma | CRISPR knockout screen followed by validation in medulloblastoma models |
| ADGRG6 | Growth plate homeostasis disorder | Knockout mouse models and chondrocyte cell lines |
| DYRK2 | Hedgehog-dependent cancers | Point-mutation of kinase domain and GLI2/GLI3 phosphorylation assays |
Chronic myeloid leukemia and BCR-ABL1-driven disease
Positive regulation of smoothened signaling contributes to the survival of drug-insensitive stem/progenitor cells in chronic myeloid leukemia. Dual targeting of Smoothened and BCR-ABL1 effectively eradicates these cells, indicating that Smoothened pathway activity is a functional dependency in CML. BCR-ABL signaling pathways intersect with Hedgehog components, providing a molecular rationale for combination strategies [3,5].
Sonic hedgehog medulloblastoma
Sonic hedgehog medulloblastoma is driven by aberrant Hedgehog pathway activity, and positive regulation of smoothened signaling is central to tumor growth. Genome-wide CRISPR-Cas9 knockout screens have identified DNMT1 as a druggable dependency in SHH medulloblastoma, demonstrating how positive regulators of the pathway can be discovered systematically.
Growth plate and skeletal disorders
The G protein-coupled receptor ADGRG6 maintains mouse growth plate homeostasis through Indian hedgehog signaling, which requires Smoothened-dependent transduction. Disruption of positive regulation of smoothened signaling can therefore contribute to growth plate abnormalities and skeletal disease.
Gastrointestinal stem cell signaling and cancer
Hedgehog signaling is integrated into gastrointestinal stem cell signaling networks, and dysregulation of positive regulation of smoothened signaling may alter stem cell behavior relevant to gastrointestinal cancers. This context highlights the importance of GO:0045880 in epithelial homeostasis and tumorigenesis.
From positive regulation of smoothened signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for positive regulation of smoothened signaling? | CRISPR knockout in Hedgehog-responsive cell lines [1,6] |
| Does a specific phosphorylation site on GLI2/GLI3 mediate positive regulation? | Point-mutation knock-in of phospho-deficient or phospho-mimetic residues |
| Does a disease-associated variant increase smoothened signaling? | Knock-in of the variant into the endogenous locus [1,5] |
| Where and when is a positive regulator expressed? | Tagged knock-in with fluorescent or epitope tag |
| Can overexpression of a regulator amplify smoothened signaling? | Overexpression cell models with inducible promoters [1,7] |
| Which genes are synthetic lethal with Smoothened activation? | Genome-wide CRISPR library screening |
How to Study the positive regulation of smoothened signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR-Cas9 knockout screen | Gene essentiality for pathway activity | Discovery of positive regulators in cancer models |
| Phosphoproteomics | Phosphorylation sites on GLI2/GLI3 | Mapping DYRK2-dependent positive regulation |
| GLI luciferase reporter | Transcriptional output of smoothened signaling | Quantifying positive regulation after perturbation |
| RNA immunoprecipitation | Smaug-mRNA interactions | Post-transcriptional control downstream of Smoothened |
| cAMP measurement | Gαs-dependent second messenger levels | Non-canonical positive regulation of smoothened signaling |
| Immunofluorescence | Subcellular localization of SMO and GLI proteins | Visualizing pathway activation [1,4] |
| qPCR of target genes | GLI1 and other Hedgehog target expression | Readout of positive regulation [1,8] |
| Mouse genetics | Growth plate and stem cell phenotypes | In vivo validation of positive regulators |
CRISPR-Cas9 knockout screens
Genome-wide CRISPR-Cas9 knockout screens can identify genes required for positive regulation of smoothened signaling. In SHH medulloblastoma, such screens identified DNMT1 as a druggable dependency, illustrating how unbiased genetic approaches reveal pathway vulnerabilities.
Phosphoproteomics and kinase assays
Because DYRK2 phosphorylates GLI2 and GLI3 to positively regulate Hedgehog signaling, phosphoproteomics and in vitro kinase assays are key methods to map the phosphorylation events that define GO:0045880.
Transcriptional reporter assays
GLI-dependent luciferase reporters and quantitative PCR of Hedgehog target genes such as GLI1 measure the output of positive regulation of smoothened signaling after genetic or pharmacological perturbation [1,7].
RNA-binding protein and post-transcriptional assays
Since Smaug is regulated by Smoothened via Fused, RNA immunoprecipitation and polysome profiling can reveal how positive regulation of smoothened signaling influences mRNA fate.
How CRISPR Can Be Used to Study GO:0045880 positive regulation of smoothened signaling pathway
Knockout
CRISPR knockout of candidate genes such as DYRK2, SMO or DNMT1 can test whether they are required for positive regulation of smoothened signaling. Genome-wide knockout screens in SHH medulloblastoma have successfully identified dependencies using this approach. Knockout models are ideal for loss-of-function causality studies [1,6].
Point Mutation
Point mutations can be introduced into kinase domains or phosphorylation sites to dissect mechanism. For example, mutating DYRK2 catalytic residues or GLI2/GLI3 phospho-acceptor sites can determine whether phosphorylation is required for positive regulation of smoothened signaling.
Knock-in
Knock-in of disease-associated variants or epitope tags allows study of positive regulation in a native genomic context. Tagged knock-in of SMO or GLI proteins enables localization and interaction studies without overexpression artifacts [1,2].
Overexpression
Overexpression of positive regulators such as DYRK2 or constitutively active SMO can amplify smoothened signaling and is useful for gain-of-function experiments. Inducible overexpression systems allow temporal control of pathway activation [1,7].
How EDITGENE Supports positive regulation of smoothened signaling pathway Research
Researchers studying positive regulation of smoothened signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway activation, whether a specific variant alters signaling strength, or whether a gene is required for cancer cell survival. EDITGENE provides the CRISPR cell model and screening services needed to answer these questions with publication-grade rigor.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of smoothened signaling pathway research.
Frequently Asked Questions About positive regulation of smoothened signaling pathway
What is GO:0045880 positive regulation of smoothened signaling pathway?
GO:0045880 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of smoothened signaling, the core Hedgehog pathway transduction arm.
What genes are involved in positive regulation of smoothened signaling pathway?
Key genes include SMO, PTCH1, DYRK2, GLI2, GLI3, Fused, Smaug, Gαs, BCR-ABL1 and DNMT1, based on published functional studies [1,2,3,5,6,7].
How does DYRK2 regulate smoothened signaling?
DYRK2 phosphorylates GLI2 and GLI3, and this phosphorylation positively regulates Hedgehog signaling by enhancing GLI transcriptional activity.
Is positive regulation of smoothened signaling involved in cancer?
Yes, it is implicated in chronic myeloid leukemia and sonic hedgehog medulloblastoma, where Smoothened pathway activity supports tumor stem and progenitor cells [5,6].
What is the role of Smoothened in the Hedgehog pathway?
Smoothened is the central transducer of Hedgehog signaling, and its positive regulation amplifies downstream GLI-dependent transcription and non-canonical outputs such as Gαs-dependent cAMP increases [1,7].
How can I study positive regulation of smoothened signaling in the lab?
Common methods include CRISPR knockout screens, phosphoproteomics, GLI luciferase reporters, RNA immunoprecipitation and cAMP measurements [1,2,6,7].
What diseases are linked to GO:0045880?
Linked diseases include chronic myeloid leukemia, sonic hedgehog medulloblastoma and growth plate homeostasis disorders [4,5,6].
What is the relationship between Smoothened and Smaug?
The RNA-binding protein Smaug is regulated by the GPCR Smoothened via the kinase Fused, connecting positive Smoothened signaling to post-transcriptional control.
Can CRISPR screens identify new regulators of smoothened signaling?
Yes, genome-wide CRISPR-Cas9 knockout screens have identified DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma, demonstrating the power of this approach.
What model systems are used to study positive regulation of smoothened signaling?
Models include Hedgehog-responsive cell lines, mouse growth plate models, CML stem cells and medulloblastoma cells, combined with CRISPR and pharmacological perturbations [1,4,5,6].
Conclusion
GO:0045880, positive regulation of smoothened signaling pathway, is a biologically process term that captures the amplification of Smoothened-dependent Hedgehog signaling. Mechanistically, it involves relief of Patched-mediated inhibition, kinase-driven GLI activation by DYRK2, non-canonical Gαs-dependent cAMP modulation and post-transcriptional control via Fused and Smaug [1,2,7]. These events are critical in development and are dysregulated in chronic myeloid leukemia, sonic hedgehog medulloblastoma and growth plate disorders [4,5,6]. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with library screening and bioinformatics, provide a rigorous path to identify and validate positive regulators of smoothened signaling. EDITGENE supports these efforts with publication-ready cell models and screening services tailored to GO:0045880 research [1,6].
References
- 1. Yoshida S et al.. 2024. Positive regulation of Hedgehog signaling via phosphorylation of GLI2/GLI3 by DYRK2 kinase.. Proc Natl Acad Sci U S A 121(28):e2320070121 PMID: 38968120
- 2. Bruzzone L et al.. 2020. Regulation of the RNA-binding protein Smaug by the GPCR Smoothened via the kinase Fused.. EMBO Rep 21(7):e48425 PMID: 32383557
- 3. Cilloni D et al.. 2012. Molecular pathways: BCR-ABL.. Clin Cancer Res 18(4):930-7 PMID: 22156549
- 4. Bian F et al.. 2024. The G protein-coupled receptor ADGRG6 maintains mouse growth plate homeostasis through IHH signaling.. J Bone Miner Res 39(11):1644-1658 PMID: 39236220
- 5. Turner KA et al.. 2025. Dual Targeting of Smoothened, a Key Regulator in the Hedgehog Pathway, and BCR-ABL1 Effectively Eradicates Drug-Insensitive Stem/Progenitor Cells in Chronic Myeloid Leukemia.. Cells 14(19) PMID: 41090792
- 6. Tsiami F et al.. 2024. Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma.. Acta Neuropathol Commun 12(1):125 PMID: 39107797
- 7. Praktiknjo SD et al.. 2018. Activation of Smoothened in the Hedgehog pathway unexpectedly increases Gα(s)-dependent cAMP levels in Drosophila.. J Biol Chem 293(35):13496-13508 PMID: 30018136
- 8. Katoh Y et al.. 2006. Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review).. Int J Mol Med 18(6):1019-23 PMID: 17089004
